Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

clover health investments corp - CLOV

CLOV

Close Chg Chg %
5.21 0.20 3.84%

Closed Market

5.41

+0.20 (3.84%)

Volume: 15.08M

Last Updated:

Jun 26, 2026, 3:59 PM EDT

Trade Now

Company Overview: clover health investments corp - CLOV

CLOV Key Data

Open

$5.21

 Day Range

5.18 - 5.49

52 Week Range

1.58 - 5.49

 Market Cap

$2.74B

Shares Outstanding

526.68M

 Public Float

405.09M

Beta

2.55

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.11

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

9.70M

  

CLOV Performance

1 Week
 
 8.20%
 
1 Month
 
 35.93%
 
3 Months
 
 209.14%
 
1 Year
 
 96.01%
 
5 Years
 
 -58.29%
 

CLOV Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 3.483
Number of Ratings 3 Current Quarters Estimate 0.039
FY Report Date 06 / 2026 Current Year's Estimate 0.039
Last Quarter’s Earnings 0.073 Median PE on CY Estimate N/A
Year Ago Earnings 0.036 Next Fiscal Year Estimate 0.051
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 3
Mean Estimate 0.04 -0.00 0.04 0.05
High Estimates 0.07 0.00 0.09 0.10
Low Estimate 0.00 -0.01 0.01 0.01
Coefficient of Variance 88.52 -104.39 115.77 88.11

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Clover Health Investments Corp - CLOV

Date Name Shares Transaction Value
Jun 17, 2026 Karen M. Soares Chief Legal Officer 1,567,741 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $4.61 per share 7,227,286.01
Jun 17, 2026 Jamie L. Reynoso CEO, Medicare Advantage 2,843,571 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $4.61 per share 13,108,862.31
Apr 22, 2026 Brady Patrick Priest CEO of Clover Care Services 2,138,261 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.19 per share 4,682,791.59
Apr 17, 2026 Andrew Toy Chief Executive Officer; Director 10,009,005 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.04 per share 20,418,370.20
Apr 17, 2026 Conrad Wai CEO, Counterpart Health 1,169,914 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.04 per share 2,386,624.56
Apr 17, 2026 Clay Thornton Interim CFO 1,234,526 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.04 per share 2,518,433.04
Jan 12, 2026 Vivek Garipalli Director 3,512,196 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 12, 2026 Vivek Garipalli Director 1,856,247 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.59 per share 4,807,679.73

Clover Health Investments Corp in the News